Alzheimer's Disease Prevention Trial

Sponsor
National Institute on Aging (NIA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000176
Collaborator
(none)
22

Study Details

Study Description

Brief Summary

This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

PREventing Postmenopausal memory loss and Alzheimer's with Replacement Estrogens (PREPARE) is a double-blind-placebo controlled trial to determine whether estrogen (or estrogen and progesterone) can delay the onset of memory loss or Alzheimer's Disease in elderly women with a family history of the disease.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Masking:
Double
Primary Purpose:
Prevention
Official Title:
Alzheimer's Disease Prevention Trial. A Multi-center, Randomized, Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimer's Disease and Loss of Memory in Women.
Actual Primary Completion Date :
Sep 1, 2007
Actual Study Completion Date :
Sep 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy women 65 or older with a family history of memory problems not currently on estrogen.
    Exclusion Criteria:
    • Significant neurological impairment

    • Current estrogen use

    • History of breast cancer

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama Birmingham Alabama United States 35294
    2 University of California, Irvine Irvine California United States 29697-4540
    3 New England Center for Headache Stamford Connecticut United States 06902-1249
    4 Howard University Washington District of Columbia United States 20060
    5 Lee Memorial Health System Fort Myers Florida United States 33901
    6 Mayo Clinic Jacksonville Jacksonville Florida United States 32225
    7 Wein Center Miami Beach Florida United States 33140
    8 West Florida Regional Medical Center Pensacola Florida United States 32514
    9 North Broward Medical Center Pompano Beach Florida United States
    10 Tallahassee Memorial Health Center Tallahassee Florida United States 32308
    11 St. Mary's Medical Center West Palm Beach Florida United States 33407
    12 Johns Hopkins Bayview Medical Center Baltimore Maryland United States 21224
    13 Neurology Group of Bergen County Ridgewood New Jersey United States 07450
    14 Columbia University New York New York United States 10032
    15 Cornell Medical Center, New York Presbyterian Medical Center New York New York United States
    16 New York United Hospital Medical Center Port Chester New York United States 10573
    17 Burke Medical Research Institute White Plains New York United States 10605
    18 Duke University Medical Center Durham North Carolina United States 27710
    19 Clinical Pharmaceutical Trials Tulsa Oklahoma United States 74104-5428
    20 Butler Hospital, Rhode Island Hospital Providence Rhode Island United States 02906
    21 Medical University of South Carolina North Charleston South Carolina United States 29406
    22 Eastern Virginia Medical School Norfolk Virginia United States 23507-1912

    Sponsors and Collaborators

    • National Institute on Aging (NIA)

    Investigators

    • Principal Investigator: Mary Sano, PhD, Icahn School of Medicine at Mount Sinai

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00000176
    Other Study ID Numbers:
    • IA0018
    • RO 1AG15922-01
    First Posted:
    Nov 1, 1999
    Last Update Posted:
    Nov 5, 2010
    Last Verified:
    Nov 1, 2010
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 5, 2010